AKL Research & Development Ltd.’s focus is in inflammatory diseases, particularly those related to dysregulation of the innate immune system.

AKLRD identifies secondary metabolites of plant origin with proven efficacy & safety, and which are capable of being synthesized. These synthetic metabolites then undergo standard pharmaceutical clinical development. This innovative approach greatly increases the chances of success, while reducing the probability of unexpected side effects.